Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress

Lifeloc Technologies, Inc

2024-Q3 EPS reported -$0.30 revenue$6,628,099

Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.
Nine-month 2024 revenue $6.628M, net loss $740K ($0.30/diluted) vs prior year profit $111K.
Gross margin improved to 43.7% in Q3 vs 41.5% last year; nine-month 41.4% vs 43.4%.
SpinDx saliva THC detection system beta testing planned this quarter; commercial launch projected later in 2025.
Raised $750K line of credit and $798K private placement (210K shares at $3.80) to fund SpinDx development.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.